The nonribosomal peptides (NRP) feature an enormous chemical diversity and have given rise to a multitude of therapeutics. 1 However, their microbial synthesis by large multifunctional synthetases complicates the construction and sampling of large libraries of novel NRPs. 2 In contrast, peptides synthesized by ribosomal translation are amenable to ultrahigh throughput screening schemes, such as mRNA display, 3 a combinatorial method that allows the sampling of more than 10 13 individual molecules. 4 In the past, however, these peptide libraries had to be constructed from the 20 canonical L-amino acidssa rather uniform set of building blocks compared to the variety of L-, D-, -, and N-methyl and R, -unsaturated amino acids from which NRPs are tailored. In an effort to reduce this limitation, we and others have shown that the in vitro translation of nonbiological polymers from unnatural L-amino acids is indeed possible with a reconstituted Escherichia coli translation system (PURE-system). [5] [6] [7] However, the ribosomal production of polymers with additional alternative backbone residues remains a challenging, 8-10 yet indispensable step toward the production of NRP-like structures in an mRNA-templated fashion.
The nonribosomal peptides (NRP) feature an enormous chemical diversity and have given rise to a multitude of therapeutics. 1 However, their microbial synthesis by large multifunctional synthetases complicates the construction and sampling of large libraries of novel NRPs. 2 In contrast, peptides synthesized by ribosomal translation are amenable to ultrahigh throughput screening schemes, such as mRNA display, 3 a combinatorial method that allows the sampling of more than 10 13 individual molecules. 4 In the past, however, these peptide libraries had to be constructed from the 20 canonical L-amino acidssa rather uniform set of building blocks compared to the variety of L-, D-, -, and N-methyl and R, -unsaturated amino acids from which NRPs are tailored. In an effort to reduce this limitation, we and others have shown that the in vitro translation of nonbiological polymers from unnatural L-amino acids is indeed possible with a reconstituted Escherichia coli translation system (PURE-system). [5] [6] [7] However, the ribosomal production of polymers with additional alternative backbone residues remains a challenging, [8] [9] [10] yet indispensable step toward the production of NRP-like structures in an mRNA-templated fashion.
One backbone alteration found in many natural products, such as lantibiotics, 11 microcystin, 12 and thiopeptide antibiotics, 13 stems from the incorporation of dehydroalanine (∆Ala, Scheme 1). R, -Unsaturated amino acids exhibit rigidifying effects on the peptide backbone, which stabilizes secondary structures and increases the proteolytic stability of the parent molecule. 14 Due to its moderate electrophilicity, ∆Ala may also serve as a warhead in proteinreactive compounds 15 and has proven to be a valuable intermediate for the preparation of cyclized, glycosylated, or prenylated peptides through intra-or intermolecular Michael addition. 16 To harness this versatility for the in vitro selection of peptides, we devised a method for constructing dehydropeptides through mRNA-templated, ribosomal peptide synthesis. Van der Donk et al. reported the use of Se-phenylselenocysteine (SecPh) as a building block for solid-phase peptide synthesis that can be converted to ∆Ala via oxidative elimination. 17 The chemical conditions for this process are compatible with biomacromolecules; however, SecPh is not a reported substrate for any of the E. coli aminoacyl tRNA synthetases and thus cannot be used for all-enzymatic peptide synthesis. To circumvent this problem, we investigated the possibility that selenalysine 18 (K Se , Scheme 1) might be an efficient substrate for lysine aminoacyl tRNA synthetase and thus be incorporated into peptides as directed by lysine codons on translated mRNAs. We further surmised that such selenopeptides might undergo oxidative elimination to expose ∆Ala in a post-translational manner (Scheme 1).
To test these ideas, we assembled a reconstituted translation system from E. coli 6 as previously described and tested the efficiency of K Se 19, 20 incorporation in place of lysine into a short peptide ( Figure 1, peptide 1) . Fifty microliter translation reactions containing the corresponding mRNA were incubated for 1 h at 37°C
. Product peptide yields were determined by purification on NTAagarose beads and 35 S-Met scintillation counting (Figure 1, left (Figure 1, left) .
As a more rigorous test of the efficiency and fidelity of lysine replacement by K Se , we prepared an mRNA containing three consecutive lysine codons. This template was also efficiently translated into selenopeptide (30 pmol/50 µL) with an observed mass of m obs ) 1883.2 Da (m calc ) 1883.6 Da), indicating that 17 The mass difference between starting material and the oxidized peptide as determined by MALDI-TOF is consistent with elimination of three formal equivalents of 2-amino ethylselenol (-3 × 125 Da) accompanied by sulfoxidation of the N-terminal methionine (+16) ( Figure 1B) . The formation of three electrophilic functions was further confirmed by intermolecular thiol conjugation by incubating the oxidized peptide with 100 mM L-cysteine ( Figure 1C ). Indeed, a large variety of nucleophiles may be reacted with ∆Ala-containing peptides, and thus our approach presents a general method for the site-directed incorporation of small molecules into translated peptides or proteins. 16 Finally, we aimed at introducing ∆Ala into cyclic peptides so as to enhance our mimicry of ∆Ala-containing natural products and ultimately set the stage for the in vitro selection of novel, druglike molecules. Biologically active peptides are very often cyclic because cyclization improves proteolytic stability, 21 membrane solubility, 22 and target affinity/specificity. 23 We exploited the recent discovery that R,R′-dibromo-m-xylene can cross-link and therefore cyclize peptides that contain two cysteine residues. 24 The two resulting thioether bonds are stable, apolar, and may improve bioavailability.
A model peptide (Figure 2 , peptide 3) was produced by in vitro translation and adsorbed onto NTA-agarose beads. These beads were then treated with 5 mM R,R′-dibromo-m-xylene and 0.2 mM tris(carboxyethyl)phosphine in a 1:4 acetonitrile:50 mM Tris-HCl buffer, pH 8.0 for 1 h at room temperature. The peptides were then eluted with 0.2% TFA and oxidized with 20 mM H 2 O 2 at pH 5.0 for 1 h and then analyzed by MALDI-TOF ( Figure 2B ). The observed mass is consistent with the desired structure with a minor signal consistent with sulfoxidation of one of the two thioethers.
Treatment of the same peptide with 200 mM H 2 O 2 led to a mixture of non-, mono-, and disulfoxidized species. Reduction of the oxidant concentration, however, led to satisfactory homogeneity. For the same reason, we chose to substitute methionine with norleucine (M Nor ), an efficient analogue with an oxidation-resistant side chain. 25 In summary, we have demonstrated the production of genetically encoded dehydropeptides. Our approach employs unmodified components from the translation machinery of E. coli and mild but robust conditions to install multiple electrophilic functions in linear or cyclic peptides. The simplicity of this methodology should allow wide applicability, making highly decorated peptides available independently of solid-phase peptide synthesis. Furthermore, having introduced ∆Ala to the toolbox of mRNA-templated peptide synthesis, we may now embark on ultrahigh throughput selections for specific protein-reactive or catalytically active compounds. Figure 2 . Incorporation of ∆Ala into a cyclic scaffold. Two concomitant SN2 reactions between two peptide-borne thiols (A, mcalc ) 1923.7 Da) and one equivalent of R,R′-dibromo-m-xylene lead to peptide cyclization. Possible side products, such as the linear adduct of two equivalents of xylene and one peptide, are not observed (B, mcalc ) 1900.8 Da). A minor signal 16 Da higher than the expected mass indicates partial sulfoxidation of the newly formed thioethers by the conditions used for ∆Ala formation.
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